FOLD - Amicus Therapeutics Inc Profit before interest, taxes and amortization
The EBITDA_Co chart demonstrates a capital reproduction model where the 42.01 level represents the current value. Amicus Therapeutics (FOLD) is implementing automated bioreactors and digital logistics control. High business scalability ensures profit growth through the global distribution of innovations. Key drivers include the commercial success of rare pathology therapies, a strong pipeline, and the expansion of Galafold and Pombiliti drugs.
Summary analytical data breakdowns for Amicus Therapeutics, Inc. (FOLD)
- current quotes and average value forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Amicus Therapeutics|FOLD - Long-Term Debt to Equity|Current Liabilities to Capital Amicus Therapeutics Inc|FOLD - Company Debts|Debt to Book Capitalization Ratio Amicus Therapeutics|FOLD - Company Long-Term Debts|Short-Term Debt Volume Amicus Therapeutics|Interim Coverage Ratio amicusrx.com
- financial results and valuation multiples details:
FOLD - Company Net Income|Future Profit Amicus Therapeutics|FOLD - P/E Multiple|Forward P/E Multiple amicusrx.com|FOLD - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Amicus Therapeutics|FOLD - Operating profit EBITDA|Net earnings per share for the last four quarters Amicus Therapeutics|FOLD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months amicusrx.com|FOLD - Net earnings per share growth this year|Earnings growth forecast for next year Amicus Therapeutics
Analysis of all company metrics:Amicus Corp (FOLD)
The stability of Amicus Therapeutics (FOLD) relies on flawless cold chain logistics for the delivery of orphan drugs, which directly converts into actual cash flow. Tracking EBITDA on the GURU.Markets platform allows for the stripping of accounting write-offs from operating profit, revealing the actual volume of sales proceeds for an objective assessment of the business's fair value.
Who Amicus Therapeutics competes with
ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|89bio Inc (ETNB) - Profit before interest, taxes and amortization|AGIO - Profit before payment of interest, taxes and amortization|GPCR: Profit before payment of interest, taxes and amortization|MDXG: Operating profit EBITDA|RZLT - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Operating profit EBITDA SGMT (Sagimet Biosciences)|Operating profit EBITDA bioagelabs.com BIOA|BMEA - Profit before payment of interest, taxes and amortization|Quince Therapeutics (QNCX) - Operating profit before deduction of amortization|GUTS: Operating profit EBITDA|VTVT - Operating income before deduction of amortization|ATPC (Agape ATP Corp) - Operating profit EBITDA|Operating profit before deduction of amortization Pluri Inc (PLUR)|Operating profit before deduction of amortization SYBX (Synlogic, Inc.)|Operating profit EBITDA Lipocine Inc (LPCN)|Profit before payment of interest, taxes and amortization Matinas BioPharma Holdings MTNB|Operating income before deduction of amortization sprucebiosciences.com (SPRB)|GLTO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CTCX (carmellrx.com)|LUMO (Lumos Pharma) - Operating profit before deduction of amortization|ONVO: Company profit before taxes, interest and amortization|RDUS (Radius Health) - Operating profit EBITDA
